Montelukast (Singulair): reminder of the risk of neuropsychiatric reactions

2019-09-19T11:40:35+01:00

Prescribers should be alert for neuropsychiatric reactions in patients taking montelukast and carefully consider the benefits and risks of continuing treatment if they occur.